Every dollar amount and date on this page is quoted from the official settlement document.
Y Mabs
Court case: Y-mAbs Therapeutics, Inc. Securities Litigation
Y-mAbs Therapeutics, Inc. settled a securities class action for $19,650,000, resolving claims that investors were misled about the company between 2020 and 2022. The settlement covered purchasers of Y-mAbs stock during that period, and the fund has already been distributed. The claim filing window closed October 7, 2024.
Official eligibility wordingPersons or entities who purchased Y-mAbs Therapeutics stock between October 6, 2020 and October 28, 2022, both dates inclusive. Checked against the official settlement source by SettleSignal on June 19, 2026.
Key facts
- Who may qualify The settlement covered persons and entities who purchased Y-mAbs Therapeutics stock between October 6, 2020 and October 28, 2022.
- Estimated payout$19,650,000.00 total settlement fund
- Claim deadlineOctober 7, 2024 (closed)
- Proof requiredYes
- What you needThe claim deadline (October 7, 2024) has passed, and the settlement is closed with funds already distributed.
- CourtUnited States District Court for the Southern District of New York
Important dates
How hard is this claim to file?
Documents you'll need
Watch out for
- The distribution has already been sent — the claims filing deadline has passed; check whether late claims are still accepted by contacting the administrator
- Both dates of the class period are inclusive, so transactions on October 6, 2020 and October 28, 2022 themselves qualify
- This settlement requires proof of purchase; automatic payment without filing is not available
We prepare — you file on the official site yourself. This is not legal advice and is not an eligibility decision; the administrator and court decide.
Verify it yourself
How we verified this record
- Claim deadline Jun 19, 2026
- Payout details Jun 18, 2026
- Eligibility Jun 18, 2026
- Proof requirement Jun 18, 2026
- Administrator Jun 19, 2026
- Official claim link Jun 19, 2026
- Payment status Jun 19, 2026
- 1 field queued for re-check
2 official sources linked to this record.
-
Claim deadline
October 7, 2024
Verified Jun 19, 2026
-
Eligibility summary Quoted in the official eligibility wording above ↑
Verified Jun 18, 2026
-
Proof requirement
Yes
Verified Jun 18, 2026
-
Payment status
Distribution complete
Verified Jun 19, 2026
The distribution has been sent.
-
Estimated payout
$19,650,000.00 total settlement fund
Verified Jun 18, 2026
-
Administrator
Strategic Claims Services
Verified Jun 19, 2026
Show all 7 more verified fields
-
Official claim URL
www.strategicclaims.net
Verified Jun 19, 2026
-
Objection deadline
October 7, 2024
Verified Jun 19, 2026
-
Opt-out deadline
October 7, 2024
Verified Jun 19, 2026
-
Class period start
October 6, 2020
Verified Jun 18, 2026
-
Class period end
October 28, 2022
Verified Jun 18, 2026
-
Court
United States District Court for the Southern District of New York
Verified Jun 18, 2026
-
Case name
Y-mAbs Therapeutics, Inc. Securities Litigation
Verified Jun 19, 2026
Where to act
